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The mammalian inner ear comprises the cochleovestibular labyrinth, derived from the ectodermal otic placode, and the encasing bony
labyrinth of the temporal bone. Epithelial–mesenchymal interactions are thought to control inner ear development, but the modes and the
molecules involved are largely unresolved. We show here that, during the precartilage and cartilage stages, Fgf9 is expressed in specific
nonsensory domains of the otic epithelium and its receptors, Fgfr1(IIIc) and Fgfr2(IIIc), widely in the surrounding mesenchyme. To address
the role of Fgf9 signaling, we analyzed the inner ears of mice homozygous for Fgf9 null alleles. Fgf9 inactivation leads to a hypoplastic
vestibular component of the otic capsule and to the absence of the epithelial semicircular ducts. Reduced proliferation of the prechondrogenic
mesenchyme was found to underlie capsular hypoplasticity. Semicircular duct development is blocked at the initial stages, since fusion plates
do not form. Our results show that the mesenchyme directs fusion plate formation and they give direct evidence for the existence of reciprocal
epithelial–mesenchymal interactions in the developing inner ear. In addition to the vestibule, in the cochlea, Fgf9 mutation caused defects in
the interactions between the Reissner’s membrane and the mesenchymal cells, leading to a malformed scala vestibuli. Together, these data
show that Fgf9 signaling is required for inner ear morphogenesis.
D 2004 Elsevier Inc. All rights reserved.
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The mammalian inner ear contains the cochleovestibular
membranous labyrinth and the encasing labyrinth of the
temporal bone. The cochlear duct and the vestibular organs
together with the semicircular ducts and the endolymphatic
duct house the membranous labyrinth. Its chambers and
ducts are filled with endolymph, an inner-ear-specific fluid.
The walls of the membranous labyrinth are made of sensory
and nonsensory epithelium. The hair cells of the cochlear
and vestibular sensory epithelia are the key cellular0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.06.010
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E-mail address: ulla.pirvola@helsinki.fi (U. Pirvola).components in hearing and balance function, respectively,
and they are innervated by the sensory neurons of the
cochlear and vestibular ganglia. The epithelial and neuronal
compartments of the inner ear are derived from an
ectodermal thickening, the otic placode. The placode
invaginates and closes to a vesicle, called the otocyst,
which develops through a series of morphogenetic events
into the mature inner ear. The mesenchyme surrounding the
otocyst starts to condense during early otocyst stages and
the outer domain of the condensing mesenchyme differ-
entiates into the cartilaginous otic capsule, which forms the
temporal bone.
Fibroblast growth factor (Fgf)–Fgf receptor (Fgfr)
signaling functions at multiple stages of development of
the mouse inner ear, as shown by Fgf and Fgfr loss-of-
function mutations. Fgfs and Fgfrs have been shown to be273 (2004) 350–360
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Wright and Mansour, 2003), otocyst morphogenesis
(Mansour et al., 1993; Pauley et al., 2003; Pirvola et al.,
2000), formation of the pool of precursor cells giving rise
to the auditory sensory epithelium (Pirvola et al., 2002),
and differentiation of supporting cells within this sensory
epithelium (Colvin et al., 1996). By a double gene
inactivation approach, Fgf3 and Fgf10 have been shown
to function redundantly in the formation of the otic
placode of the mouse (Alvarez et al., 2003; Wright and
Mansour, 2003). These two Fgfs appear to function at later
stages of inner ear development too, as evidenced by their
expression in the otocyst epithelium (Pirvola et al., 2000;
Wilkinson et al., 1989). Fgf3 and Fgf10 single null mutant
mice show dysmorphic inner ears (Mansour et al., 1993;
Pauley et al., 2003). Furthermore, Fgfr2(IIIb), encoding
the main receptor for Fgf3 and Fgf10 (Igarashi et al., 1998;
Lu et al., 1999; Ornitz et al., 1996), is expressed in the otic
epithelium (Orr-Urtreger et al., 1993; Pirvola et al., 2000)
and its inactivation leads to a severe inner ear phenotype, a
developmental arrest at the otocyst stage (De Moerlooze et
al., 2000; Pirvola et al., 2000). Fgfr2(IIIb) is distinctly
expressed in the nonsensory regions and Fgf10 in the
sensory regions of the otocyst; these results, together with
the knockout phenotypes, suggest that Fgf10/Fgfr2(IIIb)
signaling is essential for inner ear morphogenesis. In
addition to Fgf10 and Fgf3, Fgf9 has been shown to be
expressed in the otic epithelium (Colvin et al., 1999) and
its preferred receptors, Fgfr1(IIIc) and Fgfr2(IIIc) (Ornitz
et al., 1996; Santos-Ocampo et al., 1996), are mainly
expressed in the otic mesenchyme (Orr-Urtreger et al.,
1993; Pirvola et al., 2000, 2002).
Reciprocal signaling between the epithelium and
mesenchyme is a fundamental process for the morpho-
genesis of diverse organs. In organs such as the limb
bud, lung, and tooth, Fgf10 and/or Fgf7 are essential
mesenchymal signals regulating epithelial morphogenesis,
whereas epithelial Fgf9, Fgf8, Fgf4, and/or Fgf17 control
proliferation, patterning, survival, and differentiation of
the mesenchyme (Colvin et al., 2001a; Hogan, 1999;
Jernvall and Thesleff, 2000; Min et al., 1998; Sekine et
al., 1999; Sun et al., 2002). Compared to most other
developing organs studied, it is quite unique that, during
the otocyst stages, Fgf10 is expressed in the otic
epithelium rather than in the surrounding mesenchyme
(Pirvola et al., 2000). Although Fgf10 signaling appears
not to regulate inner ear morphogenesis through epithe-
lial–mesenchymal interactions, several lines of evidence
suggest that interactions between these two compartments
are essential, the otocyst providing a chondrogenic
stimulus for the mesenchyme (Frentz and Van de Water,
1991; McPhee and Van de Water, 1985) and the
mesenchyme regulating global morphogenesis of the
otocyst (Swanson et al., 1990). However, the molecular
basis of epithelial–mesenchymal interactions in the inner
ear is poorly understood.In the present study, we describe the spatiotemporal
expressions of Fgf9, Fgfr1(IIIc), and Fgfr2(IIIc) in the
embryonic inner ear and study the in vivo functions of Fgf9
signaling. We demonstrate that Fgf9 is an otic epithelial
signal stimulating growth and remodeling of the otic
mesenchyme where its receptors are expressed. Fgf9 null
mice show distinct defects in the vestibular part of the inner
ear where decreased mesenchymal proliferation leads to a
hypoplastic otic capsule and this, in turn, seems to inhibit
the formation of the epithelial fusion plates, which normally
initiate semicircular duct development. These results pro-
vide for the first time genetic evidence of an otic epithelium-
derived growth factor regulating expansion of the surround-
ing mesenchyme and of the existence of reciprocal
epithelial–mesenchymal interactions directing gross devel-
opment of the inner ear.Materials and methods
Mutant mice
Generation of mice homozygous for a targeted disruption
of Fgf9 has been previously described (Colvin et al.,
2001a,b). Genotypes were determined by PCR as described
in these papers. Fgf9 mutant mouse line used was on the
C57BL/6 background. At E10.5, E12.0, E12.5, E14.5,
E15.5, E16.5, and E18.5, both ears of 5–10 mutant embryos
were analyzed per developmental stage. In addition, eight
ears of mutants were prepared for paint-filled whole mounts
at E18.5.
Tissue preparation and histology
Whole heads of E16.5 and younger embryos and
dissected inner ears of E18.5 embryos were fixed overnight
in 4% paraformaldehyde (PFA) and embedded in paraffin
(Shandon). Five 5-Am-thick sections were stained with
hematoxylin (Shandon). For immunohistochemistry, a rabbit
polyclonal antibody directed against myosin VI (Hasson et
al., 1997) was used. Detection was done with the Vectastain
Elite ABC kit and the diaminobenzidine (DAB) substrate
(Vector Laboratories). Methyl green (Sigma) was used for
counterstaining and, following dehydration, sections were
mounted in Permount (Fisher). For cartilage staining, Scott’s
Alcian Blue (Sigma) method (Scott and Dorling, 1965) was
used. Paraffin sections were immersed in the Alcian Blue
staining buffer overnight, thereafter counterstained with
nuclear fast red (Sigma), dehydrated, and mounted in
Permount.
Proliferation and apoptosis assays
For proliferation studies, pregnant females received an
intraperitoneal injection of bromodeoxyuridine (BrdU)-
labeling reagent (Amersham-Pharmacia) 1 h before sacri-
U. Pirvola et al. / Developmental Biology 273 (2004) 350–360352fice. Deparaffinized sections were denatured with 2 N HCl
for 15 min, incubated with a monoclonal BrdU-antibody
(Neomarkers), and the reaction was detected with the
Vectastain MOM ABC kit and DAB. To detect phospho-
histone H3-positive cells, deparaffinized sections were
microwaved for 10 min in 10 mM citrate buffer (pH 6.0),
incubated with a polyclonal antibody (Cell Signaling
Technology), followed by detection with the Vectastain
Elite ABC kit and DAB. Sections were counterstained with
methyl green. To detect apoptotic cells, the fluorescein in
situ cell death detection kit was used according to
manufacturer’s (Roche) instructions.
In situ hybridization
In situ hybridization was performed with 35S-labeled
riboprobes on PFA-fixed paraffin sections according to the
protocol by Wilkinson and Green (1991). Expression of
Fgf9, Fgf10, Fgfr1(IIIc), Fgfr2(IIIb), and Fgfr2(IIIc) was
studied on each embryonic day between E9.5 and E18.5. At
least four normal inner ears per embryonic day and per
probe were analyzed. In addition, expression of Sox9, Dlx5,
Hmx2, Netrin1, and Fgf10 was compared in the inner ears
of control and Fgf9 mutants between E10.5 and E18.5. At
each stage, at least four inner ears of both mutants and
controls were analyzed per probe.
Paint-filled whole mounts
Dissected inner ears of E18.5 control and mutant
embryos were fixed overnight in 4% PFA, washed in
phosphate-buffered saline, and postfixed for 2 days in
Bodian’s fixative at +48C. Specimens were dehydrated in
ethanol and cleared in methyl salicylate (Sigma). WhiteFig. 1. Expression of Fgf9, Fgf10 and their receptors in the embryonic
mouse inner ear as revealed by radioactive in situ hybridization. (A) At
E10.5, Fgf9 is expressed in the otic epithelium, most distinctly in its
dorsolateral and ventrolateral domains. (B) At E12.5, Fgf9 is expressed in
the thin-walled nonsensory epithelium of the otocyst except the endolym-
phatic duct. The cochleovestibular ganglion shows weak expression. (C) As
shown in an adjacent section, Fgf10 is expressed in the otic epithelium in a
pattern nonoverlapping to Fgf9 distribution. Fgf10 is expressed in the
thickened regions of the otic epithelium, the presumptive sensory epithelia.
Similar to Fgf9, it is expressed in the cochleovestibular ganglion, but the
levels of expression are much higher. (D) At E13.5, Fgf9 is expressed in the
growing semicircular ducts. (E) At E16.5, Fgf9 is expressed in the
Reissner’s membrane of the cochlear duct and in the neurons of the
cochlear ganglion. Arrows mark the negative auditory sensory epithelium,
comprising the hair cells. (F,G) At E12.5, Fgfr1(IIIc) (F) and Fgfr2(IIIc)
(G) are expressed in the otic mesenchyme, most prominently around the
dorsal part of the otocyst. In addition, weak Fgfr1(IIIc) expression is seen
in the ventromedial region of the otocyst epithelium (arrow). (H) At E12.5,
Fgfr2(IIIb) expression is partly overlapping with the distribution of Fgf9
transcripts (B) in the nonsensory otic epithelium. However, the endolym-
phatic duct is positive only for Fgfr2(IIIb). Abbreviations: ot, otocyst; hb,
hindbrain; ed, endolymphatic duct; cd, cochlear duct; cvg, cochleovestib-
ular ganglion; fp, fusion plate; sd, semicircular duct; Rm, Reissner’s
membrane; cg, cochlear ganglion. Scale bar in E, 80 Am (A, D, E); 120 Am
(B, C, and F–H).paint was diluted in methyl salicylate to a concentration of
about 1% and microinjected into the cochleovestibular
membranous labyrinth as previously described (Martin and
Swanson, 1993; Morsli et al., 1998).Results
Expression of Fgf9 and its receptors in the embryonic inner
ear
Epithelial–mesenchymal interactions have been sug-
gested to control inner ear development, but only little is
known about the molecules and cellular mechanisms behind
these interactions. The importance of Fgf signaling in
epithelial–mesenchymal interactions is well established
U. Pirvola et al. / Developmental Biology 273 (2004) 350–360 353during organogenesis. We hypothesized that this might be
the case in the developing inner ear as well. Consistent with
an earlier study (Colvin et al., 1999), we found Fgf9
expression in the embryonic otic epithelium (Fig. 1). The
expression was very weak in the otocyst at E9.5 (data not
shown), but became stronger and showed initial region-
alization by the next embryonic day (Fig. 1A). Between
E11.5 and E12.5, Fgf9 was expressed in the thin-layered
nonsensory epithelium of the otocyst with the exception of
the endolymphatic duct (Fig. 1B). This expression pattern
was nonoverlapping with Fgf10 expression, which is
confined to the sensory and neurogenic patches of the
otocyst (Fig. 1C) as previously shown (Pirvola et al., 2000).
Specifically, at E12.0, Fgf9 was prominently expressed in
the outpocketings representing the primordia of the semi-
circular ducts (data not shown) and, at E12.5, in the forming
fusion plates, which initiate semicircular duct development
(Fig. 1B). At E13.5 and E14.5, Fgf9 was expressed in the
growing semicircular ducts (Fig. 1D), but this expressionFig. 2. Disturbed inner ear development in Fgf9 null mutant mice at late embryo
three semicircular ducts seen in wild-type embryos (A) are not formed in the mutan
vestibular part of the otic capsule is hypoplastic in the mutants. In addition, semic
Alcian Blue-stained sections through E16.5 heads show the hypoplasia of the ve
acoustic meatus and thinning of a medially located domain of the vestibular capsu
that despite the absence of semicircular ducts, vestibular sensory epithelia appe
Abbreviations: wt, wild type; ssd, superior semicircular duct; psd, posterior semicir
saccule; pam, ampulla associated with the posterior semicircular duct; lam, ampu
acoustic meatus. Scale bar in F, 250 Am (A, B); 140 Am (C, D); 160 Am (E, F);was downregulated by E16.5. In the extending cochlear duct
of E12.0 to E14.5 embryos, Fgf9 was expressed in the
ventral wall (Fig. 1B), which comprises the nonsensory
epithelium giving rise to the Reissner’s membrane (Sher,
1971). Consistently, cochlear ducts of E16.5 and E18.5 mice
showed Fgf9 expression in the developing Reissner’s
membrane (Fig. 1E). In addition to the otic epithelium,
low numbers of Fgf9 transcripts were detected in the
neurons of the embryonic inner ear ganglia (Fig. 1E).
Fgf9 preferentially activates the IIIc isoform of Fgfrs
(Ornitz et al., 1996; Santos-Ocampo et al., 1996).
Fgfr1(IIIc) and Fgfr2(IIIc) were widely expressed in the
otic mesenchyme. As shown at E12.5, these receptors were
expressed in the mesenchyme of both the dorsal (vestibular)
and ventral (cochlear) part of the inner ear (Figs. 1F,G).
Receptor expressions were homogeneous, except that, in the
cochlea, most Fgfr2(IIIc) transcripts were confined to the
outer ring of the otic capsule, destined for the temporal
bone, whereas the mesenchyme adjacent to the cochleargenesis. (A,B) Paint-filled whole mounts of E18.5 inner ears show that the
ts (B). (C,D) Alcian Blue-stained sections of E18.5 inner ears show that the
ircular ducts are missing and replaced by a dilated cavity (asterisks). (E,F)
stibular capsule of the mutants. Note also the enlargement of the internal
le (arrow). (G,H) Myosin-immunostained sections prepared at E18.5 show
ar normal in the mutants. Myosin marks the hair cells of the inner ear.
cular duct; lsd, lateral semicircular duct; sd, semicircular duct; ut, utricle; sa,
lla associated with the lateral semicircular duct; am, ampulla; iam, internal
70 Am (G, H).
Fig. 3. Defects in the development of the cochlea of Fgf9 null mutants at
E18.5, as shown by hematoxylin staining. (A,B) Scala vestibuli of the
mutants is enlarged and contains irregular mesenchymal trabeculi. The
auditory sensory epithelium (arrow) of the mutants appears normal. (C,D)
Higher magnification shows that the two mesenchymal cell layers normally
attached to the Reissner’s membrane are disorganized in the mutants.
Abbreviations: wt, wild type; SV, scala vestibuli, Rm, Reissner’s
membrane; ST, scala tympani; cg, cochlear ganglion; me, mesenchyme.
Scale bar in D, 60 Am (A, B); 15 Am (C, D).
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Low levels of Fgfr1(IIIc) and Fgfr2(IIIc) were detected in
the otocyst epithelium, most distinctly Fgfr1(IIIc) in the
ventromedial domain (Fig. 1F) and in the greater epithelial
ridge of the cochlear duct (data not shown; Pirvola et al.,
2002). The epithelial fusion plates were negative for these
receptors (Figs. 1F,G). Fgfr1(IIIc) and Fgfr2(IIIc) expres-
sions persisted in the mesenchyme of the late-embryonic
inner ear, but at lower levels than during otocyst stages (data
not shown; Pirvola et al., 2000). Similar to Fgf9 ,
Fgfr2(IIIb), encoding the main receptor for Fgf10 (Igarashi
et al., 1998; Lu et al., 1999), was expressed in the
nonsensory epithelium of the otocyst (Fig. 1H; Pirvola et
al., 2000). Thus, Fgfr2(IIIb) expression was largely non-
overlapping with the distribution of Fgfr1(IIIc) and
Fgfr2(IIIc) transcripts.
Fgf9-deficient mice show a malformed inner ear
Based on these expression data, we sought to determine
the in vivo functions of Fgf9 in the developing inner ear.
Mice homozygous for a targeted deletion of Fgf9 have been
generated and described to exhibit male-to-female sex
reversal and severe lung hypoplasia (Colvin et al.,
2001a,b). The mutants die at birth. As shown in paint-filled
whole mounts of the inner ears at birth, the three semi-
circular ducts seen in normal mice were not formed in the
mutants and were replaced by a large cavity (Figs. 2A,B).
Histological analyses made at late embryogenesis confirmed
these observations. Superior and posterior semicircular
ducts were absent in all mutants analyzed (Figs. 2C–F). A
rudimentary lateral duct was present in about 40% of the
mutants (Fig. 2F); the other individuals show complete
absence of this duct. Although semicircular ducts were
absent, the three ampullary sensory epithelia, which are
normally connected to these ducts, were present and showed
a normal complement of hair cells as evidenced by myosin
VI-immunostaining (Figs. 2G,H). Myosin VI marks the
differentiating and mature hair cells of the inner ear (Hasson
et al., 1997). Likewise, saccule appeared morphologically
normal as well the sensory epithelium of utricle, which,
however, was not separated into an individual chamber, but
occupied the same dilated cavity together with the ampul-
lary sensory epithelia (Figs. 2G,H). The loss of Fgf9 did not
affect endolymphatic duct development (data not shown).
In addition to the absence of semicircular ducts, another
distinct feature of the Fgf9-deficient ears was the severe
hypoplasia of the vestibular component of the otic capsule,
as demonstrated by Alcian Blue staining, which specifically
stains cartilage (Figs. 2C–F). Alcian Blue stained the
cartilaginous outer domain of the otic capsule, which
develops into the temporal bone. In addition to the general
hypoplasia of the vestibular capsule, Fgf9 inactivation
caused a prominent thinning of the cartilaginous domain
situated between the vestibular epithelium and the brain-
stem. This defect led to an increased size of the internalacoustic meatus, which conveys the 7th and 8th cranial
nerves through the temporal bone (Figs. 2E,F). In contrast to
the vestibular part of the otic capsule, the capsule around the
cochlear duct appeared normal in the mutants (Figs. 2C–F).
The length of the cochlear duct and the cytoarchitecture
of the sensory and nonsensory cochlear epithelia appeared
normal in Fgf9 null mutants, as analyzed at birth. However,
abnormalities were seen in the mesenchyme of mutant
cochleas, as evidenced by failures in the development of
scala vestibuli, a fluid-filled chamber located above the
Reissner’s membrane (Figs. 3A,B). Scala vestibuli is formed
by mesenchymal cavitation (Sher, 1971). At birth, in normal
cochleas, a distinct scala vestibuli has been formed in the
basal coil, but not yet in the later-differentiating upper turns.
Scala vestibuli of age-matched mutants was enlarged, had
an aberrant shape, and contained mesenchymal cells
forming irregular trabeculae (Figs. 3A,B). In normal mice
at birth, two mesenchymal cell layers are attached to the
Reissner’s membrane, but in age-matched mutants this
cellular organization was disturbed (Figs. 3C,D). Taken
together, although dysmorphogenesis caused by the loss of
Fgf9 is milder in the cochlea as compared to the vestibule,
phenotypic analysis coupled with the expression of Fgf9
and its receptors point to the role of Fgf9 signaling in
epithelial–mesenchymal interactions in both parts of the
developing inner ear.
We next investigated the developmental stage that is
affected by Fgf9 inactivation and that leads to the abnormal
otic capsule and the absence of semicircular ducts. The
observations made at E14.5 of the absence of these ducts
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capsule, as shown by Alcian Blue-staining (Figs. 4A,B),
suggested an early origin of the defects. In normal otocysts
at E12.0, central regions of the walls of the vertical and
horizontal outpocketings represent the primordial semi-
circular ducts. These epithelial domains are nearly in contact
with one another at E12.0 (Fig. 4C) and fuse half a day later
to generate fusion plates (Fig. 4D). At E12.0 and E12.5,
mutant otocysts appeared otherwise normal, but the out-
pocketings were dilated, without any attempt of the
opposing walls to approach one another (Figs. 4E,F). These
results indicate that the initiation of semicircular duct
development is blocked in Fgf9 null mutants due to theFig. 4. Defects at the early stages of inner ear development in Fgf9 null mutants. (A
inner ears of both controls and mutants at E14.5. Already at this stage, the mu
associated with the absence of semicircular ducts (arrows in control specimen). (C,
outpocketing giving rise to the superior semicircular duct are approaching one anot
the mutants, the walls of the outpocketing generating the superior semicircular duc
the dorsal (vestibular) part of the otocyst (arrows). (G,H) At E12.5, Sox9 is strongl
the Sox9-positive area is more restricted in mutants. Control and mutants sections
do not show morphological differences at E10.5. Abbreviations: wt, wild type; ot,
plate; hb, hindbrain. Scale bar in J, 120 Am (A, B); 60 Am (C–F, I, J); 80 Am (Ginhibition of fusion plate formation. All the mutants
analyzed lacked the formation of the fusion plates giving
rise to the superior and posterior semicircular ducts. Lateral
fusion plate was formed in some of the mutants, these
findings being consistent with the observations made at late
embryogenesis of a rudimentary lateral duct in about 40% of
the mutants. Strikingly, at E12.0 and E12.5, in addition to
the defects in the development of the epithelial fusion plates,
volume of the mesenchyme around the dorsal part of the
otocyst was clearly reduced in the mutants, as shown by
hematoxylin staining (Figs. 4C–F) and Sox9 in situ hybrid-
ization (Figs. 4G,H). Sox9 is a precocious marker for the
differentiation of mesenchymal cells into chondrocytes,B) Alcian Blue staining shows that chondrogenesis has been initiated in the
tants show prominent hypoplasia of the vestibular mesenchyme, which is
D) As shown by hematoxylin staining, in controls, the opposing walls of the
her at E12.0 and the corresponding fusion plate is formed by E12.5. (E,F) In
t remain dilated and do not fuse. Note reduced mesenchymal volume around
y expressed in the otic mesenchymal cells of both mutants and controls, but
are adjacent to D and F, respectively. (I,J) Inner ears of mutants and controls
otocyst; cvg, cochleovestibular ganglion; ed, endolymphatic duct; fp, fusion
, H).
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distinct phenotypic changes at E12, inner ears of E10.5
mutants appeared morphologically normal; these results
suggest that Fgf9 does not play a major role at the earliest
stages of inner ear development (Figs. 4I,J).
What might be the mechanism used by Fgf9 to regulate
fusion plate formation? As assayed by the TUNEL method,
no differences were observed in the extent of apoptosis
between mutant and control inner ears between E10.5 and
E18.5 (data not shown). In contrast, at E12.0 and E12.5,
clear differences were seen in proliferative activity, based on
the S-phase-specific BrdU staining and on the phospho-
histone H3-staining, which marks the M-phase of the cell
cycle. Differences in proliferative activity were evident in
the condensing otic mesenchyme, but not in the oticFig. 5. Defects in proliferative activity in the precartilage otic mesenchyme of Fgf9
of controls and Fgf9 mutants. (A) BrdU labeling shows intense proliferation throu
mutant, proliferation is clearly reduced (arrows) in the vestibular mesenchyme. No
epithelial semicircular ducts. (C,D) As shown at higher magnification in the anter
(arrows) in the mesenchyme next to the dilated outpocketing, which gives rise to
(E,F) Phospho-histone H3-immunostaining shows, in the mutant at E12.5, decrea
primordia of the semicircular ducts. Note also the reduced mesenchymal volume.
the otic epithelium of both controls and mutants at E12.0. (I,J) In situ hybridizatio
otic epithelium of mutants and controls at E12.0. The Fgf10-positive epithelial p
cochleovestibular ganglion. The migrating neuroblasts account for the expressio
cochlear duct; ed, endolymphatic duct; cvg, cochleovestibular ganglion; hb, hindbr
70 Am (G–J).epithelium (Figs. 5A–F). In controls, intense proliferation
was seen throughout the otic capsule (Fig. 5A). Fgf9
mutants showed a modest reduction in proliferation in the
mesenchyme surrounding the ventral part of the otocyst,
which develops into the cochlea (Fig. 6). Proliferation was
prominently declined in the mesenchyme around the dorsal
part of the otocyst, destined for the vestibule (Fig. 5B).
Specifically, numbers of BrdU- and phospho-histone H3-
positive cells were reduced in the mesenchymal area next to
the dilated epithelial outpocketings (Figs. 5C–F and 6),
these results being consistent with the observations of
reduced mesenchymal volume in this area. Together,
decreased mesenchymal proliferation in Fgf9 mutants
appears to inhibit approaching of the opposing walls of
the otocyst, resulting in the absence of fusion plates.null mutants (A–F). Hmx2 (G,H) and Fgf10 (I,J) expression in the otocysts
ghout the otic mesenchyme of a control embryo at E12.0. (B) In a littermate
te also the decreased mesenchymal volume and the dilated primordia of the
ior part of the inner ear at E12.0, in the mutant, BrdU labeling is decreased
the superior semicircular duct. Note also the reduced mesenchymal volume.
sed numbers of mitotic profiles (arrow) in the otic mesenchyme next to the
(G,H) As shown by radioactive in situ hybridization, Hmx2 is expressed in
n shows similar expression pattern of Fgf10 in the thickened regions of the
atches give rise to the inner ear sensory epithelia and to the neurons of the
n seen in the mesenchyme. Abbreviations: wt, wild type; ot, otocyst; cd,
ain; Rm, Reissner’s membrane. Scale bar in H, 110 Am (A, B); 60 Am (C–F);
Fig. 6. Quantification of BrdU-positive cells in the lateral and medial
regions of the vestibular mesenchyme (fields analyzed are next to the
epithelial walls of the presumptive superior semicircular duct) and in the
ventral region of the cochlear mesenchyme (next to the Reissner’s
membrane) of Fgf9 mutants and littermate controls at E12.0. Each bar
presents average from six to eight inner ears. Two sections per inner ear
were analyzed and one field of each region was analyzed per section. Error
bar represents standard deviation. Fields analyzed for a given region
(lateral, medial, ventral) are exactly from the same level of the inner ear.
Sox9 in situ hybridization was used on adjacent sections to distinguish the
otic mesenchyme from the non-otic mesenchyme. The decline in
proliferation is very clear in the vestibular areas of mutants as compared
to controls (***, P b 0.001). Differences are significant also in the cochlear
ventral region (**, P b 0.01). Student’s t test was used for statistical
analysis.
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not anymore obvious at E14.5 (data not shown), at the stage
when the mutant inner ears showed the distinct absence of
semicircular ducts.
Our results suggest that the epithelial Fgf9 signals
through its receptors present in the adjacent mesenchyme.
We did not find detectable levels of Fgfr1(IIIc) and
Fgfr2(IIIc) in the epithelial primordia of the semicircular
ducts. To confirm that the effect of Fgf9 on semicircular
duct development is not due to direct patterning changes
within the epithelium, we compared the expression of two
homeobox genes, Hmx2 (also termed as Nkx5.2) and Dlx5,
in Fgf9 mutants and controls. Hmx2 and Dlx5 are expressed
in the vestibular part of the otocyst and the knockout mice
completely lack semicircular ducts (Hmx2) or show only a
rudimentary lateral duct (Dlx5) (Acampora et al., 1999;
Depew et al., 1999; Hadrys et al., 1998; Rinkwitz-Brandt et
al., 1995; Wang et al., 2001). As analyzed between E12.0
and E14.5 (Figs. 5G,H), Hmx2 and Dlx5 were expressed in
a similar fashion in the control and mutant otocysts,
suggesting that the expression of these transcription factors
is independent of Fgf9. Netrin1 is a laminin-related protein.
Similar to Fgf9 inactivation (this study), targeted disruption
of Netrin1 leads to the absence of semicircular ducts
(Salminen et al., 2000). In both cases, fusion plate
formation is blocked. In situ hybridizations performed at
E12.0, E12.5, E15.5, and E18.5 showed that Netrin1 is
expressed in the otic epithelium of Fgf9 mutants (data not
shown). Together, these data showing that the expression of
epithelial genes known to regulate semicircular ductformation is unaffected in Fgf9 mutant mice suggest that
the direct downstream targets of Fgf9 signaling reside
within the otic mesenchyme.
Based on the knowledge that Fgf9 signaling can
modulate Fgf10 expression during organogenesis (Colvin
et al., 2001a), we studied whether the normal expression of
Fgf10 in the sensory patches and neurogenic region of the
otocyst (Pirvola et al., 2000) is maintained in the mutants.
As analyzed at E12.0 and E18.5, we found unaltered
Fgf10 expression in the mutants and, thus, this expression
in the inner ear seems to be independent of Fgf9 signaling
(Figs. 5I,J).Discussion
Epithelial–mesenchymal interactions based on Fgf9
signaling in the embryonic inner ear
In the present study, we give evidence of an epithelial
Fgf signal, Fgf9, controlling inner ear morphogenesis. Our
results suggest that, during otocyst stages, Fgf9 is involved
in interactions between the otic epithelium and the
surrounding mesenchyme where its receptors are expressed.
This is in contrast to two other Fgfs, Fgf10 and Fgf3,
which are also expressed in the otocyst epithelium, but
which signal through their common receptor, Fgfr2(IIIb),
also present in the epithelium (De Moerlooze et al., 2000;
Mansour et al., 1993; Pauley et al., 2003; Pirvola et al.,
2000).
The mesenchyme around the otocyst condenses and
forms the otic capsule, the shape of which follows the
contour of the cochleovestibular membranous (epithelial)
labyrinth. These general observations suggest an intimate
crosstalk between the otic epithelium and the mesenchyme.
In vitro experiments support this suggestion (Frentz and Van
de Water, 1991), but the molecular nature of epithelial–
mesenchymal interactions in the inner ear is poorly under-
stood. Recently, signaling by bone morphogenetic proteins
has been suggested to regulate the growth of the otic capsule
in the chick (Chang et al., 2002). The present study shows
that Fgf9 null mutants at birth have a severely hypoplastic
vestibular component of the otic capsule. This defect
appears to be due to reduced mesenchymal proliferation at
early developmental stages. We found that Fgf9 stimulates
mesenchymal proliferation mainly before E14.5. At this
stage, the null mice, lacking semicircular ducts, showed a
markedly undersized vestibular capsule, but did not show
significant differences in the extent of mesenchymal
proliferation as compared to controls. At E10.5, at the onset
of Fgf9 expression, we did not see morphological differ-
ences between the inner ears of controls and mutants.
However, reduction in the volume of the otic mesenchyme
and decrease in proliferative activity become very clear by
E12. Because Alcian Blue staining, marking chondrogenic
regions, is first detected in the otic mesenchyme at E13.5
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conclude that Fgf9 has most prominent effect on the growth
of the otic mesenchyme at the precartilage stages. This
suggestion is in line with previous data showing that one of
the receptors through which Fgf9 signals, Fgfr2(IIIc), is
strongly expressed in the precartilage mesenchymal con-
densations in the mouse embryo (Finch et al., 1995) and is
essential for skeletal development (Eswarakumar et al.,
2002; Yu et al., 2003). Sox9 was strongly expressed in the
otic mesenchyme of both controls and mutants, but the
Sox9-positive area was more restricted in the mutants, this
being consistent with the observations of reduced mesen-
chymal volume. Sox9 is a master regulator of chondro-
genesis (Akiyama et al., 2002; Bi et al., 1999). Strong Sox9
expression in the otic mesenchymal cells of Fgf9 mutants
suggests that Fgf9 does not play a major role in their
differentiation. Prominent Sox9 expression in the mutants
also suggests that it is not a downstream target for Fgf9
signaling. A candidate target gene is the POU-domain
transcription factor Brn4, which is widely expressed in the
otic mesenchyme and causes defects in otic capsular
development when inactivated (Phippard et al., 1998,
1999). However, the cellular mechanisms underlying this
phenotype have not been shown and, thus, it is at the present
unknown whether Brn4 is involved in the Fgf9-induced
proliferative pathway in the otic mesenchyme.
Reciprocal epithelial–mesenchymal interactions in the
developing inner ear
During embryogenesis, Fgf9 expression and function
in the inner ear show parallels to organs such as the
lung, testis, and tooth (Colvin et al., 2001a,b; Kettunen et
al., 1998). In all these tissues, the epithelial Fgf9
stimulates mesenchymal proliferation. In many developing
organs, Fgf signaling is involved in reciprocal interactions
between the epithelium and mesenchyme. This appears to
be the case in the inner ear as well. Our results suggest
that the initiation of semicircular duct development is
blocked in Fgf9 null mice due to decreased mesenchymal
proliferation. In normal development, a force originating
from the mesenchyme is thought to drive together the
opposing walls of the otocyst, leading to the formation of
fusion plates, which give rise to semicircular ducts. Our
study suggests that this force is, at least partly, generated
by mesenchymal expansion through cell proliferation. In
Fgf9 null mutants, the superior and posterior semicircular
ducts were always absent, but a rudimentary lateral duct
was present in about half of the specimens. These
findings imply for some degree of heterogeneity in the
molecular mechanisms underlying the initiation of devel-
opment of the three semicircular ducts.
In addition to mesenchymal proliferation, other mech-
anisms, especially those related to the extracellular matrix
(ECM), are likely to contribute to fusion plate formation.
Netrin1 is expressed in the nonsensory areas of theotocyst epithelium and its inactivation blocks the for-
mation of fusion plates (Salminen et al., 2000). Because
Netrin1 is a laminin-related protein, it has been specu-
lated that localized defects at the level of the basement
membrane and ECM contribute to the abnormal pheno-
type of Netrin1-deficient mice (Salminen et al., 2000).
Based on the similarities in the inner ear phenotype of
Netrin1 and Fgf9 null mutants, a possibility is that these
genes belong to the same genetic pathway. However, the
unaltered expression of Netrin1 in the inner ears of Fgf9
mutants suggests that Fgf9 is not an upstream regulator
of Netrin1. It has been experimentally shown in the early
inner ear of Xenopus that enzymatic destruction of
glycosaminoglycans (GAGs) blocks the inward movement
of the opposing otic epithelial faces, which normally
generate fusion plates (Haddon and Lewis, 1991).
Localized production of GAGs by these epithelial
domains has also been demonstrated (Haddon and Lewis,
1991). Thus, accumulation of GAGs in the ECM may
provide a driving force for fusion plate formation. In this
respect, it is interesting that GAGs are important
modulators of Fgf activity (reviewed by Ornitz, 2000;
Pellegrini, 2001) and, therefore, the effect of GAGs may
at least partially be exerted through regulation of Fgf9
activity.
Interestingly, in Fgf9 null mutants, similarities can be
seen in the underlying cellular mechanism causing
failures in the formation of the inner ear’s semicircular
ducts (this study) and the lung’s airways (Colvin et al.,
2001a). In both cases, the early epithelial outpocketings
remain dilated due to reduction in the amount of
surrounding mesenchyme. In the lung and limb bud,
reciprocal cross-talk between these compartments by Fgfs
is well-established. In these organs, Fgf10 is a key
mesenchymal signal and Fgf9, Fgf8, Fgf4, and/or Fgf17
are epithelial signals (Colvin et al., 2001a,b; Min et al.,
1998; Sekine et al., 1999; Sun et al., 2002). Further
evidence for Fgf-based reciprocal signaling comes from
the lungs of Fgf9 null mice in which Fgf10 expression in
the mesenchyme is reduced (Colvin et al., 2001a). The
present findings suggest that reciprocal epithelial–mesen-
chymal interactions operate in the developing inner ear as
well. However, in contrast to organogenesis of many
other tissues and to the stages of otic placode induction
when Fgf10 is transiently expressed in the mesenchyme
next to the placode (Alvarez et al., 2003; Wright and
Mansour, 2003), Fgf10 is expressed in the otic epithelium
rather than in the surrounding mesenchyme at the otocyst
stages. Thus, Fgf10 signaling appears not to be involved
in epithelial–mesenchymal interactions at the otocyst
stages. However, in addition to the force generated by
the expanded otic mesenchyme, a diffusible mesenchymal
signal is likely to be involved in driving the opposing
otic epithelial walls together. The identity of this putative
signal is at the moment unknown. Although Fgf10 is not
expressed in the mesenchyme surrounding the otocyst,
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Fgf10 expression through intricate signaling loops
between the epithelium and mesenchyme. However, our
expression studies on Fgf9 mutants do not support this
possibility.
The present data show that, in the inner ear, Fgf9 null
mutation has strongest effect on the development of the
vestibule, but defects are also seen in the cochlea.
Consistent with the observations of Fgf9 expression in the
developing Reissner’s membrane and its receptors in the
adjacent mesenchyme, the normal attachment of mesen-
chymal cells to the Reissner’s membrane failed in Fgf9
mutants and resulted in an enlarged and trabeculated scala
vestibuli. Thus, in addition to the function at the prechon-
drogenic stages, Fgf9 has a role in the later-developing inner
ear, in the remodeling of the cochlear mesenchyme. The
remodeling process continues postnatally (Sher, 1971), but
the lethality of Fgf9 mutants at birth prevented us from
following disturbances in this process at later stages. The
observed defects in the interaction between adjacent
epithelial and mesenchymal cell sheets suggest that the
extracellular properties such as cell adhesion and cell
migration are affected, and, thus, speak for the involvement
of the ECM in Fgf9 signaling during cochlear development.
Taken together, our results on the cochleas of Fgf9 mutants
support the conclusions made in the vestibule that Fgf9
signaling is involved in epithelial–mesenchymal interac-
tions. The observations of unaltered expression of Dlx5 and
Hmx2 in the otocysts of Fgf9 mutants suggest that these
epithelial transcription factors do not serve as downstream
targets for Fgf9. These observations further support our
suggestion that the direct targets for the otic epithelium-
derived Fgf9 signal reside in the mesenchyme.
In conclusion, the present study provides genetic
evidence for the role of Fgf9 signaling in inner ear
morphogenesis, specifically in the growth of the otic capsule
and the initiation of semicircular duct formation. Our data
point to the importance of cross-talk between the epithelium
and mesenchyme in global shaping of the inner ear. In this
respect, Fgf9 signaling in the inner ear shows parallels to
many other developing organs. Our future studies will aim
at identifying the downstream targets for Fgf9 signaling in
the otic mesenchyme and at placing Fgf9 in the network of
otic epithelial genes known to affect semicircular duct
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